Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells

By Modha Geetanjalee   Blanchard Anne   Sidorchuk Janine   Venditti Marcello   Shiu Robert   Myal Yvonne  

Endocrine Journal, Vol. 22, Iss. 3, 2003-12 ,pp. : 293-303

Humana Press, Inc

Access to resources Recommend Favorite

Hormone catalysis: Role of protecting and modifying reagents of sulfhydryl groups on estrogen receptor in breast cancer

By Salazar Edith   Calzada Leobardo  

Gynecological Endocrinology, Vol. 24, Iss. 1, 2008-01 ,pp. : 30-32

Informa Healthcare

Access to resources Recommend Favorite

Clinical Relevance of Estrogen Receptor Variants in Breast Cancer

By Wiltschke C.   Fuqua S.A.W.  

Trends in Endocrinology and Metabolism, Vol. 6, Iss. 3, 1995-04 ,pp. : 77-82

Elsevier

Access to resources Recommend Favorite

What’s New in Decoding Breast Cancer

By  

Medical Principles and Practice, Vol. 21, Iss. 2, 2011-10 ,pp. : 99-100

Karger

Access to resources Recommend Favorite

Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor

By Milewicz T.   Kolodziejczyk J.   Krzysiek J.   Basta A.   Sztefko K.   Kurek S.   Stachura J.   Gregoraszczuk E. L.  

Gynecological Endocrinology, Vol. 16, Iss. 4, 2002-08 ,pp. : 319-329

Informa Healthcare

Access to resources Recommend Favorite